Boston Scientific Corp (BSX)
73.15
-0.11
(-0.15%)
USD |
NYSE |
Apr 26, 16:00
73.15
0.00 (0.00%)
After-Hours: 18:24
Boston Scientific Cash from Operations (TTM): 2.503B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.503B |
| September 30, 2023 | 2.353B |
| June 30, 2023 | 2.125B |
| March 31, 2023 | 1.774B |
| December 31, 2022 | 1.526B |
| September 30, 2022 | 1.197B |
| June 30, 2022 | 1.192B |
| March 31, 2022 | 1.528B |
| December 31, 2021 | 1.87B |
| September 30, 2021 | 2.065B |
| June 30, 2021 | 2.243B |
| March 31, 2021 | 1.869B |
| December 31, 2020 | 1.508B |
| September 30, 2020 | 1.527B |
| June 30, 2020 | 1.386B |
| March 31, 2020 | 1.409B |
| December 31, 2019 | 1.836B |
| September 30, 2019 | 1.163B |
| June 30, 2019 | 1.162B |
| March 31, 2019 | 467.00M |
| December 31, 2018 | 310.00M |
| September 30, 2018 | 975.00M |
| June 30, 2018 | 926.00M |
| March 31, 2018 | 1.626B |
| December 31, 2017 | 1.426B |
| Date | Value |
|---|---|
| September 30, 2017 | 1.418B |
| June 30, 2017 | 935.00M |
| March 31, 2017 | 1.059B |
| December 31, 2016 | 1.182B |
| September 30, 2016 | 926.00M |
| June 30, 2016 | 1.365B |
| March 31, 2016 | 1.004B |
| December 31, 2015 | 691.00M |
| September 30, 2015 | 711.00M |
| June 30, 2015 | 649.00M |
| March 31, 2015 | 874.00M |
| December 31, 2014 | 1.269B |
| September 30, 2014 | 1.104B |
| June 30, 2014 | 1.009B |
| March 31, 2014 | 1.121B |
| December 31, 2013 | 1.11B |
| September 30, 2013 | 1.224B |
| June 30, 2013 | 1.245B |
| March 31, 2013 | 1.255B |
| December 31, 2012 | 1.28B |
| September 30, 2012 | 1.24B |
| June 30, 2012 | 1.334B |
| March 31, 2012 | 1.317B |
| December 31, 2011 | 1.008B |
| September 30, 2011 | 1.108B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
1.162B
Minimum
Jun 2019
2.503B
Maximum
Dec 2023
1.697B
Average
1.528B
Median
Mar 2022
Cash from Operations (TTM) Benchmarks
| Stryker Corp | 3.711B |
| Abbott Laboratories | 7.261B |
| Edwards Lifesciences Corp | 895.80M |
| Intuitive Surgical Inc | 1.708B |
| Axonics Inc | -2.016M |